Because miR-130b-3p targets the AMPK inhibitor ROCK1106, HOTAIR could promote NAFLD indirectly through the miR-130-3p/ROCK1/AMPK axis. Here, PRKAA2 is linked to metabolic dysfunction-associated steatotic liver disease.